Exposure to HIV drug in the womb may increase risk of microcephaly, developmental delays in children
National Institutes of Health (NIH) sent this bulletin at 11/18/2019 02:30 PM ESTHaving trouble viewing this email? View it as a Web page.
You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH).
Exposure to HIV drug in the womb may increase risk of microcephaly, developmental delays in children
11/18/2019 01:45 PM EST
NIH-funded study finds higher risks for children of women who took efavirenz during pregnancy.
Update Your E-mail Address | Add Subscriptions | Unsubscribe
If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. For all other inquiries about NIH programs and activities, please contact Ask NIH. Before writing, please view our Frequently Asked Questions page, our Health Information page, or Search our website.
This service is provided to you by the National Institutes of Health.
NIH…Turning Discovery Into Health®
 |